Annual Report

Report overview

The report describes GSK's resilient 2020 performance despite COVID-19, with Group sales growing 1% at actual exchange rates and 3% at constant exchange rates. It highlights the company's COVID-19 vaccine, adjuvant and therapeutic collaborations. The report also records new goals for net-zero climate impact and net-positive impact on nature by 2030. Workforce disclosures cover gender diversity, employee engagement and two employee fatalities plus an additional work-related contractor fatality.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 8 March 2021
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Energy consumption
Employees
Women on the board
Women in management
Workplace fatalities
Net zero target

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services